• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.

作者信息

Rasooly G, Olitzki A L, Sulitzeanu D

出版信息

Isr J Med Sci. 1966 Sep-Oct;2(5):569-84.

PMID:5970644
Abstract
摘要

相似文献

1
Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.用灭活疫苗对布鲁氏菌进行免疫接种。布鲁氏菌细胞壁及其衍生组分在小鼠体内的免疫活性。
Isr J Med Sci. 1966 Sep-Oct;2(5):569-84.
2
Immunization against Brucella with killed baccines. 3. Experiments in mice.用灭活疫苗对布鲁氏菌进行免疫接种。3. 小鼠实验。
Isr J Med Sci. 1968 Mar-Apr;4(2):246-51.
3
Immunization against Brucella with killed vaccines. II. Immunizing activity of killed Brucella vaccines in guinea pigs.用灭活疫苗对布鲁氏菌进行免疫接种。II. 灭活布鲁氏菌疫苗在豚鼠中的免疫活性。
Isr J Med Sci. 1967 Nov-Dec;3(6):814-21.
4
[Thyroid gland activity after anti-brucellosis immunization and in experimental brucellosis].[抗布鲁氏菌病免疫接种后及实验性布鲁氏菌病中的甲状腺活动]
Zh Eksp Klin Med. 1974;14(6):15-9.
5
Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.用布鲁氏菌重组DnaK和SurA蛋白进行疫苗接种可诱导BALB/c小鼠对流产布鲁氏菌感染产生保护作用。
Vaccine. 2007 Sep 17;25(37-38):6721-9. doi: 10.1016/j.vaccine.2007.07.002. Epub 2007 Jul 23.
6
Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.布鲁氏菌羊种B115作为抗羊种布鲁氏菌和绵羊布鲁氏菌感染的粗糙型表型疫苗的评估。
Vaccine. 2008 Sep 8;26(38):4913-7. doi: 10.1016/j.vaccine.2008.07.030. Epub 2008 Aug 15.
7
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.以含CpG寡脱氧核苷酸作为佐剂，用细菌铁蛋白或P39重组蛋白对BALB/c小鼠进行免疫接种，以保护其免受流产布鲁氏菌544的攻击。
Infect Immun. 2001 Aug;69(8):4816-22. doi: 10.1128/IAI.69.8.4816-4822.2001.
8
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.一种基于将来自Omp31的27个氨基酸插入BLS N端的重组亚单位疫苗，诱导出的抗绵羊布鲁氏菌保护程度与Rev.1疫苗接种相似。
Vaccine. 2007 May 30;25(22):4437-46. doi: 10.1016/j.vaccine.2007.03.028. Epub 2007 Apr 2.
9
[Brucellosis protective antigen, its chemical and immunobiological characteristics].[布鲁氏菌病保护性抗原及其化学和免疫生物学特性]
Biull Eksp Biol Med. 1976 Mar;81(3):333-5.
10
Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.用布鲁氏菌 melitensis WR201 进行口服疫苗接种可保护小鼠免受强毒布鲁氏菌 melitensis 16M 的鼻内攻击。
Infect Immun. 2004 Jul;72(7):4031-9. doi: 10.1128/IAI.72.7.4031-4039.2004.

引用本文的文献

1
Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay.利用单克隆抗体鉴定七种布鲁氏菌表面暴露的外膜蛋白：用于电子显微镜的免疫金标记和酶联免疫吸附测定。
Infect Immun. 1990 Dec;58(12):3980-7. doi: 10.1128/iai.58.12.3980-3987.1990.
2
The immunogenic activity of ribosomal fractions derived from Brucella abortus.源自流产布鲁氏菌的核糖体组分的免疫原活性。
J Hyg (Lond). 1976 Feb;76(1):65-74. doi: 10.1017/s0022172400054954.
3
Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
布鲁氏菌组分对小鼠实验性布鲁氏菌病免疫保护作用的研究。I.免疫血清的积极作用。
Immunology. 1978 Aug;35(2):213-21.
4
Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice.用组分（F8）或灭活疫苗（H38）接种并添加或不添加佐剂的小鼠对布鲁氏菌的免疫力。免疫力的水平和持续时间与疫苗剂量、再次注射及小鼠年龄的关系。
Br J Exp Pathol. 1978 Aug;59(4):354-65.